PEPTONIC MEDICAL (28L) — Defensive Interval Ratio

Latest as of December 2023: 48 days

PEPTONIC MEDICAL (28L) has a Defensive Interval Ratio of 48 days as of December 2023. Defensive assets of €4.13 Million (cash €-, short-term investments €-, receivables €4.13 Million) cover 48 days of daily cash needs of €86.07K/day.

Defensive Interval Ratio

48 days
Days of operational coverage

Defensive Assets

€4.13 Million
Cash + ST Investments + Receivables

Daily Cash Need

€86.07K
Current Liabilities ÷ 365

Current Liabilities

€31.41 Million
EUR

PEPTONIC MEDICAL Defensive Interval Ratio (2021–2023)

This chart shows how PEPTONIC MEDICAL's Defensive Interval Ratio has evolved across 3 annual periods from 2021 to 2023. As of December 2023, the ratio stands at 48 days, meaning defensive assets of €4.13 Million can fund 48 days of operations without new revenue. For the complete balance sheet picture, see PEPTONIC MEDICAL total assets.

Annual Defensive Interval Ratio for PEPTONIC MEDICAL (2021–2023)

The table below presents the year-by-year Defensive Interval Ratio for PEPTONIC MEDICAL from 2021 to 2023, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of PEPTONIC MEDICAL to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2023 48 days €4.13 Million €86.07K/day €- €- ▼ -27 days
2022 75 days €7.24 Million €96.07K/day €- €- ▲ +15 days
2021 60 days €5.17 Million €86.25K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)